Influenza News and Research

Latest Influenza News and Research

MinuteClinic launches health condition monitoring services for diabetes, asthma and high cholesterol patients

MinuteClinic, the largest provider of retail-based medical clinics in the United States, has introduced a series of convenient health condition monitoring services to help patients previously diagnosed with diabetes, asthma, high cholesterol and high blood pressure overcome the challenges of living with their conditions. Health condition monitoring is available at MinuteClinic locations in CVS/pharmacy stores in 20 states and the District of Columbia. MinuteClinic is the retail health care division of CVS Caremark (CVS).

2 Apr 2010

Company affiliation is the greatest driver of farm-to-farm disease transmission risk: Study

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the potential influence that the business connections between broiler chicken growers may have on the transmission of avian influenza, H5N1. According to the study, the risk of between-farm transmission is significantly greater among farms within the same company group than it is between farms with different company affiliation.

31 Mar 2010

National Doctors' Day: St. Jude Children's Research Hospital honors physicians and staff

As physicians nationwide are acknowledged for their talent, sacrifice and courage on National Doctors' Day, St. Jude Children's Research Hospital honors its more than 230 staff and consulting physicians who strive to fulfill the hospital's mission each day.

31 Mar 2010

CDC, Surgeon General report on increased number of H1N1 cases in southeast U.S.

Although H1N1 (swine flu) "has waned across much of the United States, the southeast is reporting an increase in cases of the H1N1 virus, U.S. health officials said on Monday," Reuters reports.

31 Mar 2010

First Edition: March 30, 2010

Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. Meanwhile, the headlines also indicate that for Democrats, politically capitalizing on the new measure will be no easy task.

30 Mar 2010

Regenstrief Institute awarded Recovery Act contract to automate disability case determinations

The Regenstrief Institute has been awarded a Recovery Act contract to help the U.S. Social Security Administration and Indiana healthcare providers shorten and improve the process of making disability case determinations through automation. Work is scheduled to begin March 31.

30 Mar 2010

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.

30 Mar 2010

Decision Resources: Only 52.2% of first-line Alzheimer's disease patients prescribed AChEI

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that while approximately 70 percent of surveyed physicians' newly diagnosed patients have mild-to-moderate Alzheimer's disease, only 52.2 percent of first-line patients are prescribed an acetylcholinesterase inhibitor.

30 Mar 2010

Preclinical study of DAS181 for treatment and prevention of ILI published

NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.

30 Mar 2010

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

30 Mar 2010

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

29 Mar 2010

Final results from Novavax' Phase II clinical trial of trivalent seasonal influenza VLP vaccine announced

Novavax, Inc. a clinical-stage vaccine company, released the final results from a Phase II clinical trial evaluating Novavax's trivalent seasonal influenza Virus-like particle (VLP) vaccine candidate in healthy adults. The study enrolled healthy volunteers 18 to 49 years in age who were immunized with a single injection of Novavax's trivalent seasonal influenza VLP vaccine matched to the influenza strains recommended for the 2008-2009 influenza vaccine.

29 Mar 2010

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.

29 Mar 2010

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today it has entered into exclusive license, supply and distribution agreements with Parenteral Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd., an India-based pharmaceutical company. Pursuant to the agreements, Parenteral is authorized to register, supply and distribute Sinovac's Anflu (seasonal influenza vaccine) and PANFLU.1 (H1N1 vaccine) to the government of India and private market in India. Currently, the registration process is ongoing in India.

29 Mar 2010

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.

29 Mar 2010

Antiviral treatment may lead to drug-resistant H1N1 virus: NIAID

Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

27 Mar 2010

New ways to halt the rise of antimicrobial-resistant infections

Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.

27 Mar 2010

Study: Surgical masks prevented hospital staff from acquiring H1N1

The effectiveness of ordinary surgical masks as opposed to respirators in protecting health care workers against the 2009 H1N1 influenza virus has been the subject of debate. An observational study published in the April 1, 2010 issue of Clinical Infectious Diseases, available online, suggests that surgical masks are just as effective as respirators in this regard.

26 Mar 2010

Researchers identify link between socioeconomic status and common disease symptoms

Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.

26 Mar 2010

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.

26 Mar 2010

Influenza News and Research

Latest Influenza News and Research

MinuteClinic launches health condition monitoring services for diabetes, asthma and high cholesterol patients

Company affiliation is the greatest driver of farm-to-farm disease transmission risk: Study

National Doctors' Day: St. Jude Children's Research Hospital honors physicians and staff

CDC, Surgeon General report on increased number of H1N1 cases in southeast U.S.

First Edition: March 30, 2010

Regenstrief Institute awarded Recovery Act contract to automate disability case determinations

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

Decision Resources: Only 52.2% of first-line Alzheimer's disease patients prescribed AChEI

Preclinical study of DAS181 for treatment and prevention of ILI published

GenVec announces discontinuation of TNFerade PACT trial for pancreatic cancer

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Final results from Novavax' Phase II clinical trial of trivalent seasonal influenza VLP vaccine announced

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Antiviral treatment may lead to drug-resistant H1N1 virus: NIAID

New ways to halt the rise of antimicrobial-resistant infections

Study: Surgical masks prevented hospital staff from acquiring H1N1

Researchers identify link between socioeconomic status and common disease symptoms

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in